Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acquisition and Persistence of Rifampicin Resistance in Staphylococcus Aureus During and After Treatment for Latent Tuberculosis

NCT05073926 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT05073926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05073926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acquisition and Persistence of Rifampicin Resistance in Staphylococcus Aureus During and After Treatment for Latent Tuberculosis
Lead sponsor
Region Skane
Phase
Observational
Overall status
Active, not recruiting
Start date
September 30, 2021
Completion date
December 31, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

latent tuberculosis, staphylococcus aureus